579 related articles for article (PubMed ID: 19522449)
1. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
3. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
[TBL] [Abstract][Full Text] [Related]
4. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
5. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
[TBL] [Abstract][Full Text] [Related]
6. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):23-8. PubMed ID: 24505888
[TBL] [Abstract][Full Text] [Related]
8. [Osteodensitometry in children and adolescents with inflammatory bowel disease].
Kluge G; Borte M; Richter T; Kahn T; Borte G
Rofo; 2007 Jan; 179(1):58-64. PubMed ID: 17203445
[TBL] [Abstract][Full Text] [Related]
9. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
Scheer K; Kratzsch J; Deutscher J; Gelbrich G; Borte G; Kiess W
Klin Padiatr; 2004; 216(2):62-6. PubMed ID: 15106075
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
[TBL] [Abstract][Full Text] [Related]
11. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
Henderson S; Hoffman N; Prince R
Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
[TBL] [Abstract][Full Text] [Related]
14. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.
Noble CL; McCullough J; Ho W; Lees CW; Nimmo E; Drummond H; Bear S; Hannan J; Millar C; Ralston SH; Satsangi J
Aliment Pharmacol Ther; 2008 Apr; 27(7):588-96. PubMed ID: 18194505
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
[TBL] [Abstract][Full Text] [Related]
16. [Low bone mineral density in children with Crohn's disease].
Bourges O; Dorgeret S; Alberti C; Hugot JP; Sebag G; Cézard JP
Arch Pediatr; 2004 Jul; 11(7):800-6. PubMed ID: 15234375
[TBL] [Abstract][Full Text] [Related]
17. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of osteoporosis in inflammatory bowel disease.
Reinshagen M; Von Tirpitz C
Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
[TBL] [Abstract][Full Text] [Related]
20. Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?
Walldorf J; Krummenerl A; Engler K; Busch J; Dollinger MM; Seufferlein T; Albert JG
J Crohns Colitis; 2013 Dec; 7(11):901-7. PubMed ID: 23333038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
